Waterdrop introduces insurance for recurring breast cancer

The product offers up to $41.38k of insurance benefits. 

Insurance and health services focussed technology firm Waterdrop has launched an insurance product for recurring breast cancer.

The National Cancer Institute’s (NCI) SEER statistics revealed that the breast cancer recurrence rate is as much as 30%. According to the 2022 White Paper on the Quality of Life of Breast Cancer Patients in China, more than 70% of breast cancer patients are worried about recurrence. 

ALSO READ: OneDegree increases cover for home appliances

The product features a low threshold, flexible insured amount, wide coverage, and no deductible for Anti-Cancer Drugs. The insurance plan is open to people at Stages 0-III, with no subtype restrictions.

The plan offers up to $41.38k (RMB300k) of insurance benefits for the recurrence of breast cancer, and the insured may also choose  $41.38k (RMB300)k of benefits for healthcare and $68.97k (RMB 500k)of benefits for wonder drugs. It also has 100% payment within the coverage, no deductible for Anti-Cancer Drugs

Policyholders are also provided services such as psychological counselling and healthcare management to help them to have a better mindset and scientific healthcare management.

This product is available to people aged between 18 and 65 years old, and the age limit may be extended to 75 when the insured renews his/her policy without interruption.